回复阿塞尔博等人。β受体阻滞剂在无左心室收缩功能障碍的心肌梗死患者中真的重要吗？对“萨比娜等人。心肌梗死且左心室射血功能保留患者的β受体阻滞剂：随机对照试验的系统评价和荟萃分析。2025年，，150”的评论。
Reply to Acerbo et al. Do Beta-Blockers Really Matter in Patients with Myocardial Infarction Without Left Ventricular Systolic Dysfunction? Comment on "Sabina et al. Beta-Blockers in Patients with Myocardial Infarction and Preserved Left Ventricular Ejection: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. 2025, , 150".
作者信息
Sabina Michael, Trube Jennifer, Luna Graciela, Bizanti Anas
机构信息
Department of Internal Medicine Graduate Medical Education, Lakeland Regional Health Medical Center, Lakeland, FL 33805, USA.
出版信息
J Clin Med. 2025 Mar 26;14(7):2249. doi: 10.3390/jcm14072249.
Abstract
We appreciate the insightful commentary by Acerbo et al [...].
摘要
我们感谢Acerbo等人富有见地的评论[……]。
相似文献
1
Reply to Acerbo et al. Do Beta-Blockers Really Matter in Patients with Myocardial Infarction Without Left Ventricular Systolic Dysfunction? Comment on "Sabina et al. Beta-Blockers in Patients with Myocardial Infarction and Preserved Left Ventricular Ejection: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. 2025, , 150".回复阿塞尔博等人。β受体阻滞剂在无左心室收缩功能障碍的心肌梗死患者中真的重要吗？对“萨比娜等人。心肌梗死且左心室射血功能保留患者的β受体阻滞剂：随机对照试验的系统评价和荟萃分析。2025年，，150”的评论。
J Clin Med. 2025 Mar 26;14(7):2249. doi: 10.3390/jcm14072249.
2
Do Beta-Blockers Really Matter in Patients with Myocardial Infarction Without Left Ventricular Systolic Dysfunction? Comment on Sabina et al. Beta-Blockers in Patients with Myocardial Infarction and Preserved Left Ventricular Ejection: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. . 2025, , 150.β受体阻滞剂对无左心室收缩功能障碍的心肌梗死患者真的重要吗？对萨比娜等人的评论。β受体阻滞剂在心肌梗死且左心室射血功能保留的患者中的应用：随机对照试验的系统评价和荟萃分析。2025年，第150期。
J Clin Med. 2025 Mar 26;14(7):2247. doi: 10.3390/jcm14072247.
3
Beta-Blockers in Patients with Myocardial Infarction and Preserved Left Ventricular Ejection: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.心肌梗死且左心室射血功能保留患者使用β受体阻滞剂：一项随机对照试验的系统评价和荟萃分析
J Clin Med. 2024 Dec 30;14(1):150. doi: 10.3390/jcm14010150.
4
Reply to Dietvorst et al. Challenges in Providing an Overview of Results of Intermittent Fasting Interventions on Diabetes Parameters. Comment on "Silva et al. Effects of Intermittent Fasting on Regulation of Metabolic Homeostasis: A Systematic Review and Meta-Analysis in Health and Metabolic-Related Disorders. 2023, , 3699".对迪特沃斯特等人的回应。间歇性禁食干预对糖尿病参数影响的结果概述面临的挑战。对“席尔瓦等人。间歇性禁食对代谢稳态调节的影响：健康与代谢相关疾病的系统评价和荟萃分析。2023年，，3699”的评论。
J Clin Med. 2024 Jul 12;13(14):4094. doi: 10.3390/jcm13144094.
5
Reply to Confalonieri et al. Comment on "Benekos et al. Intraocular Pressure Reduction Following Phacoemulsification in Patients with Exfoliation: A Systematic Review and Meta-Analysis. 2024, , 6774".对孔法洛涅里等人的回复。对“贝内科斯等人。剥脱性患者白内障超声乳化术后眼压降低：一项系统评价和荟萃分析。2024年，，6774”的评论。
J Clin Med. 2025 Apr 9;14(8):2571. doi: 10.3390/jcm14082571.
6
Early intravenous beta-blockers in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: A patient-pooled meta-analysis of randomized clinical trials.ST段抬高型心肌梗死患者接受直接经皮冠状动脉介入治疗时早期静脉注射β受体阻滞剂：一项随机临床试验的患者汇总荟萃分析。
Eur Heart J Acute Cardiovasc Care. 2020 Aug;9(5):469-477. doi: 10.1177/2048872619830609. Epub 2019 Feb 14.
7
Heart failure with preserved left ventricular ejection fraction in patients with acute myocardial infarction.急性心肌梗死患者左心室射血分数保留的心力衰竭
Arq Bras Cardiol. 2015 Aug;105(2):145-50. doi: 10.5935/abc.20150055. Epub 2015 May 29.
8
Beta-blocker prescription and outcomes in uncomplicated acute myocardial infarction: Insight from the ePARIS registry.β受体阻滞剂在非复杂性急性心肌梗死中的处方情况及预后：来自ePARIS注册研究的见解
Arch Cardiovasc Dis. 2023 Jan;116(1):25-32. doi: 10.1016/j.acvd.2022.10.007. Epub 2022 Dec 9.
9
Reply to Su et al. Comment on "Matsumoto et al. Remimazolam's Effects on Postoperative Nausea and Vomiting Are Similar to Those of Propofol after Laparoscopic Gynecological Surgery: A Randomized Controlled Trial. 2023, , 5402".对苏等人的回复。关于“松本等人。瑞马唑仑对腹腔镜妇科手术后恶心和呕吐的影响与丙泊酚相似：一项随机对照试验。2023年，，5402”的评论 。
J Clin Med. 2024 Feb 9;13(4):1002. doi: 10.3390/jcm13041002.
10
Reply to Mikhail et al. Comment on "Krysik et al. Clinical Outcomes and Early Postoperative Complications in Boston Type I Keratoprosthesis Implantation: A Retrospective Study. . 2024, , 6710".回复米哈伊尔等人。对“克里西克等人。波士顿I型人工角膜植入术的临床结果和术后早期并发症：一项回顾性研究。2024年，，6710”的评论。
J Clin Med. 2025 Feb 27;14(5):1614. doi: 10.3390/jcm14051614.
本文引用的文献
1
Beta-Blockers in Patients with Myocardial Infarction and Preserved Left Ventricular Ejection: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.心肌梗死且左心室射血功能保留患者使用β受体阻滞剂：一项随机对照试验的系统评价和荟萃分析
J Clin Med. 2024 Dec 30;14(1):150. doi: 10.3390/jcm14010150.
2
Discontinuation of β-blocker therapy in stabilised patients after acute myocardial infarction (SMART-DECISION): rationale and design of the randomised controlled trial.急性心肌梗死后病情稳定患者停用β受体阻滞剂治疗（SMART-DECISION）：随机对照试验的原理与设计
BMJ Open. 2024 Aug 31;14(8):e086971. doi: 10.1136/bmjopen-2024-086971.
3
Beta-Blocker Interruption or Continuation after Myocardial Infarction.心肌梗死后β受体阻滞剂的中断或继续。
N Engl J Med. 2024 Oct 10;391(14):1277-1286. doi: 10.1056/NEJMoa2404204. Epub 2024 Aug 30.
4
Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction.心肌梗死后射血分数保留的β受体阻滞剂
N Engl J Med. 2024 Apr 18;390(15):1372-1381. doi: 10.1056/NEJMoa2401479. Epub 2024 Apr 7.
5
Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT).无射血分数降低的心肌梗死后使用β受体阻滞剂治疗的实用性临床试验（REBOOT）的原理与设计
Eur Heart J Cardiovasc Pharmacother. 2022 May 5;8(3):291-301. doi: 10.1093/ehjcvp/pvab060.
6
The impact of SSRIs on mortality and cardiovascular events in patients with coronary artery disease and depression: systematic review and meta-analysis.SSRI 类抗抑郁药对冠心病合并抑郁患者死亡率和心血管事件的影响：系统评价和荟萃分析。
Clin Res Cardiol. 2021 Feb;110(2):183-193. doi: 10.1007/s00392-020-01697-8. Epub 2020 Jul 2.
7
Design and rationale of the Danish trial of beta-blocker treatment after myocardial infarction without reduced ejection fraction: study protocol for a randomized controlled trial.丹麦试验：心肌梗死后无射血分数降低的β受体阻滞剂治疗的设计和原理：一项随机对照试验的研究方案。
Trials. 2020 May 23;21(1):415. doi: 10.1186/s13063-020-4214-6.
8
BEtablocker Treatment After acute Myocardial Infarction in revascularized patients without reduced left ventricular ejection fraction (BETAMI): Rationale and design of a prospective, randomized, open, blinded end point study.贝他阻滞剂治疗血运重建后左心室射血分数未降低的急性心肌梗死患者（BETAMI）：一项前瞻性、随机、开放、盲终点研究的原理和设计。
Am Heart J. 2019 Feb;208:37-46. doi: 10.1016/j.ahj.2018.10.005. Epub 2018 Oct 25.
9
Long-term use of carvedilol in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者中长期应用卡维地洛。
PLoS One. 2018 Aug 28;13(8):e0199347. doi: 10.1371/journal.pone.0199347. eCollection 2018.
10
Sertraline treatment of major depression in patients with acute MI or unstable angina.舍曲林治疗急性心肌梗死或不稳定型心绞痛患者的重度抑郁症。
JAMA. 2002 Aug 14;288(6):701-9. doi: 10.1001/jama.288.6.701.
Zotero 插件